April 25, 2022 by Chain Drug Review
Andre Persaud, Brian Nightengale, NACDS
Leading Headlines, Pharmacy
PALM BEACH, Fla. – During the National Association of Chain Drug Stores (NACDS) Annual Meeting, NACDS elected new officers, two new executive committee members and three newly elected board of directors members for the coming year. Additionally, NACDS re-elected nine board of directors members whose terms were set to expire. Brian Nightengale, president, Good Neighbor
April 24, 2022 by Chain Drug Review
2022 NACDS Annual, Colleen Lindholz, NACDS, NACDS president and chief executive officer Steven Anderson
Featured Articles, Leading Headlines, Pharmacy
PALM BEACH, Fla. – At the National Association of Chain Drug Stores (NACDS) Annual Meeting Sunday, industry leaders commended NACDS-member retailers and suppliers for their ongoing collaboration and commitment to serving the American people — and emphasized the vital role the united industry can play in driving the future of total health and wellness. Colleen Lindholz,
April 14, 2022 by NACDS staff
NACDS
Leading Headlines, Pharmacy
The great strength of NACDS is the relationships that fuel collaboration. The NACDS Annual Meeting not only brings together the industry’s most influential business leaders to connect, engage, learn and seize the future – it also provides an opportunity for members of the Palm Beach, Florida community to deliver one-of-a-kind products to conference attendees. For more than
April 8, 2022 by Chain Drug Review
NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. — Last week, Darren Herring, district director for House Armed Services Committee member U.S. Rep. Trent Kelly (R, Miss.), visited a Kroger in Tupelo, Miss., where he got a firsthand understanding of the vital role pharmacies continue to play in meeting the total health and wellness needs of Rep. Kelly’s constituents. The Kroger
March 31, 2022 by Chain Drug Review
NACDS, NACDS Annual Meeting
Leading Headlines, Pharmacy, Videos
ARLINGTON, Va. — NACDS looks forward to welcoming back NACDS chain and associate members to the fast-approaching NACDS Annual Meeting, to be held April 23-26 in Palm Beach, Fla. The highly anticipated, in-person event will deliver one-of-a-kind opportunities for senior executives and team members — from NACDS-member retailers and suppliers — to strengthen relationships, connect
March 31, 2022 by Chain Drug Review
NACDS, Vaccines National Strategic Plan 2021-2025 (VNSP 2021-2025) and VFIP
Leading Headlines, Pharmacy
ARLINGTON, Va. — On Tuesday, the National Association of Chain Drug Stores submitted comments to the Office of Infectious Disease and HIV/AIDS Policy (OIDP) in response to the draft Vaccines Federal Implementation Plan (VFIP) and in support of VFIP’s primary objective: to increase overall immunization rates across the nation by increasing accessibility of vaccinations to Americans and strengthening the
March 25, 2022 by Chain Drug Review
NACDS, Steve Anderson is president and chief executive officer of the National Association of Chain Drug Stores.
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS president and CEO Steven Anderson issued the following statement today related to the introduction of bipartisan legislation in the U.S. House of Representatives (HR 7213) that would help ensure the continuity of accessible pharmacy-based care: “Americans appreciated access to trusted, convenient and equitable pharmacies and pharmacy teams throughout the pandemic. The
March 17, 2022 by Chain Drug Review
022 NACDS Annual Meeting, Karl Rove, NACDS
Leading Headlines, Pharmacy, Retail News, Supplier News
ARLINGTON, Va. — NACDS announced that Karl Rove, senior advisor and deputy chief of staff for then-President George W. Bush, will speak at the National Association of Chain Drug Stores (NACDS) Political Action Committee (NACDS-PAC) Breakfast during the in-person 2022 NACDS Annual Meeting, to be held April 23-26 in Palm Beach, Fla. While at the
March 17, 2022 by Chain Drug Review
Lisa Sun, NACDS
Leading Headlines, Pharmacy, Retail News, Supplier News
ARLINGTON, Va. – Lisa Sun, founder and CEO of GRAVITAS, is set to speak at the in-person 2022 National Association of Chain Drug Stores (NACDS) Annual Meeting in Palm Beach, FL, where she will share with attendees empowering and experience-driven insights on how to harness their “superpower,” and use “gravitas” to advance both personally and professionally. Sun
March 15, 2022 by Chain Drug Review
Lynn Fruth, NACDS
Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — Lynne Fruth, president and chairman of Fruth Pharmacy and a member of the NACDS Board of Directors, has been inducted into the West Virginia Executive Health Care Hall of Fame. West Virginia Executive magazine – which provides in-depth business news coverage and highlights the state’s growth and development – launched the Health Care Hall
March 11, 2022 by Chain Drug Review
Biden Administration to finalize the Centers for Medicare and Medicaid Services’ (CMS) proposed rule for contract year 2023, NACDS
Leading Headlines, Pharmacy
WASHINGTON – On Monday, March 7, 233 patient advocates, healthcare entities, pharmacy associations, retail organizations and companies urged the Biden Administration to finalize the Centers for Medicare and Medicaid Services’ (CMS) proposed rule for contract year 2023 — so that Medicare patients obtain maximum savings and maintain convenient and equitable access to pharmacies serving them in the
March 11, 2022 by Chain Drug Review
NACDS, pandemic
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS released on Friday poll results that show significant support for extending the policies that have allowed Americans to access essential services from their pharmacies during the pandemic. NACDS has urged the Biden Administration to provide clarity or to take definitive action to ensure Americans maintain access to pharmacy services that will
March 7, 2022 by Chain Drug Review
NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. — Today, the National Association of Chain Drugs Stores (NACDS) submitted comments to the Biden Administration in support of the Centers for Medicare and Medicaid Services’ (CMS) proposal to reduce prescription drug prices for Medicare Part D patients by providing transparency regarding pharmacy direct and indirect remuneration (DIR) fees. CMS’ proposed rule would revise the
March 7, 2022 by Chain Drug Review
NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va. – NACDS president and CEO Steven Anderson issued the following statement Monday following statements by the American Medical Association (AMA) regarding the Test to Treat Initiative for COVID-19 antivirals that was mentioned by President Joe Biden and released by the Biden Administration last week. “The AMA’s criticism of the role of pharmacy-based clinics in the